Italia markets closed
Dow Jones
34.002,92 +39,08 (+0,12%) Nasdaq
13.269,90 +58,09 (+0,44%) Nikkei 225
32.678,62 +276,21 (+0,85%) EUR/USD
1,0595 -0,0052 (-0,49%) Bitcoin EUR
24.868,27 -110,89 (-0,44%) CMC Crypto 200
563,42 +3,91 (+0,70%)
BLUE Jan 2025 2.500 call
OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
Al 03:29PM EDT. Mercato aperto.
| Chiusura precedente | 1,5000 |
| Aperto | 1,6000 |
| Denaro | 1,5000 |
| Lettera | 1,6000 |
| Prezzo d'esercizio | 2,50 |
| Scadenza | 2025-01-17 |
| Min-Max giorno | 1,5000 - 1,6000 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | 1,95k |
GlobeNewswireReal Endpoints Marketplace announces collaboration with bluebird bio to help scale delivery of a first-of-its-kind value-based contract for one-time gene therapy
The risk-sharing agreement removes economic uncertainties, enabling regional and mid-sized health plans to provide patients with transfusion-dependent beta-thalassemia access to ZYNTEGLOFLORHAM PARK, N.J., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Real Endpoints, the leading market-access platform and advisory firm, announced a collaboration with bluebird bio, inc. (Nasdaq: BLUE), to provide multiple health plans with access to an innovative, outcomes-based agreement for ZYNTEGLO® (betibeglogene autotem
© 2023 Yahoo. Tutti i diritti riservati.
